100 related articles for article (PubMed ID: 24123013)
1. In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin.
Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
Anticancer Res; 2013 Oct; 33(10):4439-43. PubMed ID: 24123013
[TBL] [Abstract][Full Text] [Related]
2. Effects of structural modifications of daunorubicin on in vitro antileukemic activity.
Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
Anticancer Res; 2012 Dec; 32(12):5271-7. PubMed ID: 23225426
[TBL] [Abstract][Full Text] [Related]
3. Cell-cycle disturbance and induction of programmed death by new formamidine analogs of daunorubicin.
Stojak M; Lukawska M; Oszczapowicz I; Opydo-Chanek M; Mazur L
Anticancer Res; 2014 Dec; 34(12):7151-8. PubMed ID: 25503143
[TBL] [Abstract][Full Text] [Related]
4. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A
Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
[TBL] [Abstract][Full Text] [Related]
6. Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells.
Nakaoka E; Tanaka S; Onda K; Sugiyama K; Hirano T
Anticancer Res; 2015 Nov; 35(11):6041-8. PubMed ID: 26504027
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells.
Marczak A; Denel-Bobrowska M; Rogalska A; Łukawska M; Oszczapowicz I
Environ Toxicol Pharmacol; 2015 Jan; 39(1):369-83. PubMed ID: 25561091
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment.
Al-Aamri HM; Irving HR; Bradley C; Meehan-Andrews T
BMC Cancer; 2021 Apr; 21(1):438. PubMed ID: 33879127
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a phenoxazine compound, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis, and necrosis.
Koshibu-Koizumi J; Akazawa M; Iwamoto T; Takasaki M; Mizuno F; Kobayashi R; Abe A; Tomoda A; Hamatake M; Ishida R
J Cancer Res Clin Oncol; 2002 Jul; 128(7):363-8. PubMed ID: 12136250
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012
[TBL] [Abstract][Full Text] [Related]
11. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of new derivatives of daunorubicin.
Wasowska-Lukawska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
In Vivo; 2007; 21(2):413-6. PubMed ID: 17436596
[TBL] [Abstract][Full Text] [Related]
13. Drug sensitivity assay for leukaemic cells by flow cytometry.
Gupta M; Naik S; Pandey CM; Dabadghao S
Indian J Med Res; 2002 Jun; 115():260-4. PubMed ID: 12440199
[TBL] [Abstract][Full Text] [Related]
14.
Mazur L; Opydo-Chanek M; Śladowska K; Janota B; Kłaput U; Łukawska M; Oszczapowicz I
Anticancer Res; 2017 Nov; 37(11):6363-6372. PubMed ID: 29061821
[TBL] [Abstract][Full Text] [Related]
15. Comparison of
Opydo-Chanek M; Śladowska K; Blicharski K; Mikeš J; Fedoročko P; Niemeyer U; Mazur L
Anticancer Res; 2017 Nov; 37(11):6355-6361. PubMed ID: 29061820
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cells with different mitochondrial membrane potential during apoptosis.
Lugli E; Troiano L; Ferraresi R; Roat E; Prada N; Nasi M; Pinti M; Cooper EL; Cossarizza A
Cytometry A; 2005 Nov; 68(1):28-35. PubMed ID: 16184612
[TBL] [Abstract][Full Text] [Related]
17. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
Zhou RQ; Gong YP; Zheng BH; Yang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442
[TBL] [Abstract][Full Text] [Related]
18. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
19. Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes.
Durrieu F; Belloc F; Lacoste L; Dumain P; Chabrol J; Dachary-Prigent J; Morjani H; Boisseau MR; Reiffers J; Bernard P; Lacombe F
Exp Cell Res; 1998 May; 240(2):165-75. PubMed ID: 9596989
[TBL] [Abstract][Full Text] [Related]
20. Histological Subtype of Ovarian Cancer as a Determinant of Sensitivity to Formamidine Derivatives of Doxorubicin - in Vitro Comparative Studies with SKOV-3 and ES-2 Cancer Cell Lines.
Denel-Bobrowska M; Lukawska M; Oszczapowicz I; Marczak A
Asian Pac J Cancer Prev; 2016; 17(9):4223-4231. PubMed ID: 27797222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
